Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma

ConclusionsHigh ‐dose anlotinib combined with epirubicin was an effective and safe therapy for STS.

Source: Cancer Medicine - May 13, 2020 Category: Cancer & Oncology Authors: Zhi ‐Ming Wang, Shi‐Long Zhang, Hua Yang, Rong‐Yuan Zhuang, Xi Guo, Han‐Xing Tong, Yong Zhang, Wei‐Qi Lu, Yu‐Hong Zhou Tags: ORIGINAL RESEARCH Source Type: research